Bernhard Kreymann, Adj. Prof., MD, founder, invented the Hepa Wash® procedure and has been fulltime CEO of Hepa Wash GmbH since its foundation in July 2005. He was interims head of the nephrology department of the University Hospital rechts der Isar. Bernhard has gained in-depth expertise in extracorporeal blood purification systems and several years of experience in treatment of patients with liver failure. In 1995, he developed his first liver support therapy: Single-Pass Albumin Dialysis (SPAD) which is clinically effective but not cost-efficient enough to be applied on a large scale. Based on the experiences with this first system he invented in 2002 the Hepa Wash procedure and founded Hepa Wash® to bring this new technology to market.
Catherine Schreiber, Dipl. Ing. Mechanical Engineering, Dipl. International Business Management, studied mechanical engineering at the Technical University in Munich. She has been working with Hepa Wash since 2006 and developed and built the laboratory prototype for Hepa Washs animal studies. Catherine is supervising the developmental process, and finalizing the specifications and the risk analysis of the Hepa Wash® device.
Ahmed Al-Chalabi, MD, M.Sc. Medical Engineering, MB Ch.B., is responsible for the planning, preparation, execution, and analysis of the preclinical studies and future clinical studies as well as regulatory approval. Ahmed has worked for three years as a physician, received his master’s degree at the TU Munich, Germany, in 2006, and has been working at Hepa Wash since 2005.